Category Archives: Pr Newswire

Netcore Cloud Dominates Asia Pacific Marketing Automation: Report by an Independent Research Firm

The report notes, “Netcore Cloud is the only vendor evaluated that introduced a new way to use email — as a transaction hub.” SYDNEY, Aug. 23, 2024 /PRNewswire/ — Netcore Cloud, a comprehensive customer experience platform, has been named a Strong Performer in the prestigious Forrester Wave™: Email Marketing Service Providers, Q3 2024. As per […]

Zhihu Inc. Reports Unaudited Second Quarter 2024 Financial Results

BEIJING, Aug. 23, 2024 /PRNewswire/ — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended June 30, 2024. Second Quarter 2024 Highlights Total revenues were RMB933.8 million (US$128.5 million) in the second quarter of 2024, compared with RMB1,044.2 […]

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Today, Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company in the United States for an aggregated purchase price, including upfront and earn out payments, estimated to approximately USD 477 million. GOTHENBURG, Sweden, Aug. 23, 2024 /PRNewswire/ — With the acquisition of Paragonix Technologies – […]

Alzheimer’s Association Commends United Kingdom’s Approval of Leqembi, But Condemns Decision to Deny NHS Access

CHICAGO, Aug. 23, 2024 /PRNewswire/ — The Alzheimer’s Association welcomes today’s decision by the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqembi® (lecanemab) for the treatment of Alzheimer’s disease. However, while celebrating this milestone — the first Alzheimer’s disease modifying treatment approved in the U.K. — the decision by the National […]

Introducing LISSOME R1 the most compact and smart portable Dishwasher: Revolutionizing Cleaning for Small Spaces

LOS ANGELES, Aug. 23, 2024 /PRNewswire/ — LISSOME R1, this revolutionary compact dishwasher will soon be launched on Kickstarter. With its remarkable 11-inch width, this revolutionary appliance is designed to seamlessly fit into even the most cramped of  kitchens, whether you’re a busy urbanite, a growing family, or an adventure-seeking RV enthusiast. In many countries […]

Stryker announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions

Portage, Michigan, Aug. 22, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis. Lumbar spinal stenosis affects millions of people globally […]

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

WARREN, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, announced today that the management team will participate in two upcoming investor conferences in September 2024 as follows: H.C. Wainwright […]

Arcutis to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

WESTLAKE VILLAGE, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference. Details for the company’s participation are as follows: Fireside Chat Date: Thursday, September 5, 2024Fireside Chat […]

Starton Therapeutics Strengthens Clinical Development Strategy Following Successful Scientific Advisory Board Meeting at ASCO 2024

Scientific advisory board highly encouraged by STAR-LLD early Phase 1b data in multiple myeloma Strengthened the clinical strategy to focus on addressing major unmet medical needs and pursuing efficient pathways towards product registration: CLL: In high-risk patients refractory to Bruton tyrosine kinase (BTK) inhibitors MM: A Phase 2 study with STAR-LLD in the post-transplant maintenance […]

CervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies

BOSTON, Aug. 22, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced its recent feature in Fortune magazine. In the article, titled “A New Hope for Dementia Treatment”, CervoMed was recognized for its pioneering work in developing neflamapimod, a potentially transformative treatment […]